Darnatein

Darnatein is testing Design Augmented (DA) RNA and protein biotherapeutics, such as DaRT101 and DaRT102, for the treatment of age-related spinal and joint cartilage diseases. Currently available treatments for patients with spinal and joint cartilage diseases involve pain management through surgery or non-steroidal anti-inflammatory drugs. DaRT101 offers a new mechanism of action as a potential DMOAD (disease-modifying osteoarthritis drug).